Cacti Therapeutics announced that it will be hosting a lab day event at the Cacti Lab on September 15, 2026.
Public source
Company
Cacti
Psychedelic Therapies for Pain and Headache
- Location
- Dallas, US
- Company size
- 11–50 employees
About Cacti
Cacti is a biotech company advancing FDA approved, first-in-class "Nociplastigens" to treat chronic pain, inflammation, and opioid use disorder. Our interdisciplinary team aims to understand the psychological drivers of pain and bring transformative therapies to the patients at the heart of our mission.
See moreLatest activity
Latest activity from Cacti
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Psychedelic Support
Psychedelic Support announced the inaugural R.I.S.E. Summit, scheduled for November 12, 2026 in Irvine, California, featuring a full day on psych*edel!c research and emerging models of care for opioid use disorder and addiction.
Presence & Recognition
OPEN Foundation
OPEN Foundation is hosting a talk by Balázs Szigeti, PhD on Tuesday 8 September 2026 examining how functional unblinding shapes psychedelic trial design and interpretation.
Presence & Recognition
Johns Hopkins Center for Psychedelic and Consciousness Research
Johns Hopkins Center for Psychedelic and Consciousness Research is hosting a satellite event for SfN 2026: Advancing Cross-Species Research in Psychedelic Neurosciences on Friday, November 13, 2026 at the Marriott Marquis Washington, DC.
Presence & Recognition
Psychedelics Today
Psychedelics Today announced that Psychedelic State(s) of America founder and Investigative Journalist Jack Gorsline and The Psychedelic Bar Association are hosting a live discussion on Beyond the FDA Hearing on Tuesday, September 8th, 2026
Presence & Recognition
Compass Pathways